Yvonne Awards 2026

Meet the Scientific Co-Chairs of the ESMO Congress 2026

FDA Issues Complete Response Letter for Retifanlimab Plus Chemotherapy in Metastatic NSCLC

Leandro Jonata Oliveira: Real-World Data on Oncotype DX in Early Breast Cancer

Michael Hofman: PSMA-PET Risk Groups Redefine Prostate Cancer Prognosis

PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers: MiNK Therapeutics and C-Further Partner to Advance Development

Oncology with Common Sense in Metastatic Breast Cancer - ecancer

Richard Scolyer: A Personal Update Before the Next Treatment Milestone

support strategies